Leptin's long-distance call to the pancreas

Dec 22, 2008
More insulin-positive cells (brown) occur in mice lacking leptin-making fat cells (left) than in control mice (right). Image from: Hinoi, E., et al. 2008. J. Cell Biol. doi:10.1083/jcb.200809113.

Rube Goldberg—the cartoonist who devised complex machines for simple tasks—would have smiled at one of leptin's mechanisms for curbing insulin release. As Hinoi et al. show, the fat-derived hormone enlists the sympathetic nervous system to prevent bone-making cells from releasing a molecule that prods the pancreas to discharge insulin.

The study will appear online December 22, 2008 (www.jcb.org) and in the December 29, 2008 print issue of The Journal of Cell Biology (JCB).

In the fight against obesity and diabetes, leptin is one of the good guys. Mice lacking the hormone become corpulent, and their sky-high insulin levels eventually lead to diabetes. Leptin can curtail insulin release directly. But there's also a back-door route that researchers are still trying to piece together. Scientists knew that leptin nudges osteoblasts, cells known for building bone but that also manufacture osteocalcin, a protein that stimulates insulin release. Hinoi et al. tested whether leptin acts on the pancreas through osteocalcin.

Leptin channels many of its effects through the nervous system. The team thus tested whether the hormone relied on the sympathetic nervous system, the branch that pumps out adrenaline during emergencies but at other times emits a hormonal trickle to maintain a low level of stimulation. This baseline activity was lower in mice lacking the leptin receptor, indicating a connection between leptin and the sympathetic nervous system. When that connection was broken by deleting the adrenaline receptor from mice osteoblasts, insulin levels shot up.

The researchers then dosed mice with a sympathetic stimulator. Rodents lacking leptin or the adrenaline receptor on their osteoblasts turned out normal amounts of osteocalcin, but much of it was in an inert form. That result suggests leptin affects insulin release by indirectly inactivating osteocalcin. The work boosts researchers' hopes of using osteocalcin to treat diabetes—a possibility some drug companies have already started to investigate.

Citation: Hinoi, E., et al. 2008. J. Cell Biol. doi:10.1083/jcb.200809113

Source: Rockefeller University

Explore further: No walk in the park for S. Africa's embattled game rangers

add to favorites email to friend print save as pdf

Related Stories

Monkeys fear big cats less, eat more, with humans around

49 minutes ago

Some Monkeys in South Africa have been found to regard field scientists as human shields against predators and why not if the alternative is death by leopard? The researchers found the monkeys felt far safer ...

Report: China to declare Qualcomm a monopoly

2 hours ago

(AP)—Chinese regulators have concluded Qualcomm Inc., one of the biggest makers of chips used in mobile devices, has a monopoly, a government newspaper reported Friday.

Recommended for you

Invasive lionfish likely safe to eat after all

3 hours ago

Scientists have learned that recent fears of invasive lionfish causing fish poisoning may be unfounded. If so, current efforts to control lionfish by fishing derbies and targeted fisheries may remain the ...

Molecular gate that could keep cancer cells locked up

13 hours ago

In a study published today in Genes & Development, Dr Christian Speck from the MRC Clinical Sciences Centre's DNA Replication group, in collaboration with Brookhaven National Laboratory (BNL), New York, ...

User comments : 0